Key result
Higher peak aortic velocity linked to ~43% greater risk of symptomatic deterioration.
Why the study?
The prognostic importance of LV hypertrophy and abnormal non-invasive measures of LV diastolic function in patients with severe aortic stenosis is uncertain.
Do tissue Doppler measures of LV systolic and diastolic function or LV mass predict symptomatic deterioration in asymptomatic patients with moderate or severe aortic stenosis?
Cohort (n=183)
Do tissue Doppler measures of LV systolic and diastolic function or LV mass predict symptomatic deterioration in asymptomatic patients with moderate or severe aortic stenosis?
Hazard Ratio: 1.43 (95% CI 1.25–1.64)
p-value: p=< 0.0001
In asymptomatic patients with moderate or severe aortic stenosis and normal LVEF, tissue Doppler measures of LV function and LV mass do not provide incremental prognostic value beyond the severity of stenosis.
May inform follow-up intensity via peak aortic velocity in asymptomatic aortic stenosis; leaves open incremental value of tissue Doppler measures.
AIMS: Left ventricular (LV) hypertrophy and abnormal non-invasive measures of LV diastolic function are common in patients with severe aortic stenosis (AS) but their prognostic importance is uncertain. This study aimed to determine whether tissue Doppler measures of LV systolic and/or diastolic function or echocardiographic LV hypertrophy are useful for risk stratifying asymptomatic patients with severe calcific AS. METHODS AND RESULTS: One hundred and eighty-three initially asymptomatic patients with moderate or severe AS (valve area mean 0.96 ± SD 0.3 cm(2)) and a normal LV ejection fraction were followed for median 31 (IQR 14-40) months. Peak systolic (S') and diastolic (E') mitral annular velocities and LV mass were measured by echocardiography at baseline and during follow-up. During follow-up 106 (58%) patients suffered symptomatic deterioration, including three sudden deaths and one resuscitated cardiac arrest. Peak aortic velocity (for 0.5 m/s increase HR = 1.43, 95% CI 1.25, 1.64, P < 0.0001) and aortic valve area (-0.1 cm(2)/m(2) HR = 1.23, 95% CI 1.12, 1.35, P = 0.004) at baseline were most strongly associated with symptomatic deterioration. After peak aortic velocity adjustment neither LV mass index nor any measure of LV systolic or diastolic function was associated with symptomatic deterioration (P > 0.2 for all). CONCLUSION: In patients with calcific AS who have a normal LV ejection fraction the severity of stenosis is the most important correlate of symptomatic deterioration. Tissue Doppler measures of LV systolic and diastolic function and LV mass provide limited predictive information after accounting for the severity of stenosis.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2010) conducted a cohort in asymptomatic aortic stenosis (n=183). Peak aortic velocity and tissue Doppler measures of LV function was evaluated on symptomatic deterioration (HR 1.43, 95% CI 1.25-1.64, p=< 0.0001). Higher peak aortic velocity was strongly associated with symptomatic deterioration (HR 1.43; 95% CI 1.25-1.64; P<0.0001), while tissue Doppler measures of LV function provided limited predictive value.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: